Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 17Thoracic 8Lymphoid 8Genitourinary 7Breast 6Dermatologic 4CNS 4Plasma cell 3Other solid neoplasm 3Other hematologic neoplasm 3Head & Neck 3Tumor-Agnostic 2Sarcoma 2Gynecologic 2Other neoplasm 1Myeloid 1

Conditions

Pleural Effusion, Malignant 2Mesothelioma, Malignant 2All Solid Tumors 1

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pharmaceutical Preparations × Other solid neoplasm × Clear all
NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT07192900 2026-01-15

(RIOT 4A)

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed
15 enrolled
Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡